Cargando…
An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid
Wnt/β-catenin signalling controls development and tissue homeostasis. Moreover, activated β-catenin can be oncogenic and, notably, drives colorectal cancer. Inhibiting oncogenic β-catenin has proven a formidable challenge. Here we design a screen for small-molecule inhibitors of β-catenin's bin...
Autores principales: | de la Roche, Marc, Rutherford, Trevor J., Gupta, Deepti, Veprintsev, Dmitry B., Saxty, Barbara, Freund, Stefan M., Bienz, Mariann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293410/ https://www.ncbi.nlm.nih.gov/pubmed/22353711 http://dx.doi.org/10.1038/ncomms1680 |
Ejemplares similares
-
The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
por: de la Roche, Marc, et al.
Publicado: (2008) -
Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
por: van Tienen, Laurens M, et al.
Publicado: (2017) -
Correction: Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
por: van Tienen, Laurens M, et al.
Publicado: (2017) -
Allosteric Remodelling of the Histone H3 Binding Pocket in the Pygo2 PHD Finger Triggered by Its Binding to the B9L/BCL9 Co-Factor
por: Miller, Thomas C.R., et al.
Publicado: (2010) -
Modulating β-catenin/BCL9 interaction with cell-membrane-camouflaged carnosic acid to inhibit Wnt pathway and enhance tumor immune response
por: Gao, Ruqing, et al.
Publicado: (2023)